论文部分内容阅读
目的:观察依那普利联合丹参酮2A治疗慢性肺源性心脏病急性期并心衰的临床疗效。方法:采取随机抽样住院病人92例分治疗组、对照组各46例,对照组给予常规综合治疗,治疗组在常规综合治疗的基础上给予依那普利.丹参酮2A治疗两周。结果:治疗组总有效率95.65%,对照组89.13%(P<0.05)。结论:依那普利联合丹参酮2A治疗慢性肺源性心脏病急性期并心衰疗效良优于对照组。
Objective: To observe the clinical efficacy of enalapril combined with tanshinone 2A in the treatment of acute cor pulmonale and heart failure in patients with chronic cor pulmonale. Methods: A total of 92 randomized inpatients were divided into treatment group and control group, with 46 cases in each group. The control group was given conventional comprehensive treatment. Enalapril was given to the treatment group on the basis of conventional comprehensive treatment for 2 weeks. Results: The total effective rate was 95.65% in the treatment group and 89.13% in the control group (P <0.05). Conclusion: Enalapril combined with tanshinone 2A is superior to control group in the treatment of chronic cor pulmonale and acute heart failure.